'Salience syndrome' replaces 'schizophrenia' in DSM-V and ICD-11: Psychiatry's evidence-based entry into the 21st century?

Acta Psychiatrica Scandinavica

Volumn 120, Issue 5, 2009, Pages 363-372

  Van Os, J ^a,b,c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Diagnosis; Psychotic disorders; Schizophrenia

Indexed keywords

ARTICLE; COGNITIVE DEFECT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE COURSE; EVIDENCE BASED MEDICINE; FOLLOW UP; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; NOMENCLATURE; PHENOTYPE; PRIORITY JOURNAL; PROBABILITY; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; SALIENCE SYNDROME; SCHIZOPHRENIA; SYMPTOM; VALIDITY;

ADOLESCENT; ADULT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EVIDENCE-BASED MEDICINE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; PHENOTYPE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; YOUNG ADULT;

EID: 70349664425     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2009.01456.x     Document Type: Article

References (67)

1. Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: its applications to schizophrenia. Am J Psychiatry 1970 126 : 983 987.
2. Brockington I. Schizophrenia: yesterday's concept. European Psychiatry 1992 7 : 203 207.
3. Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry 2003 160 : 4 12.
4. van Praag HM. About the impossible concept of schizophrenia. Compr Psychiatry 1976 17 : 481 497.
5. Bentall R. Madness explained. psychosis and human nature. London : Penguin Books, 2004.
6. Linscott RJ, Allardyce J, van Os J. Seeking Verisimilitude in a Class: a systematic review of evidence that the criterial clinical symptoms of schizophrenia are taxonic. Schizophr Bull DOI : [Epub ahead of print].
7. Kendler KS, McGuire M, Gruenberg AM, Spellman M, O'Hare A, Walsh D. The Roscommon Family Study. II. The risk of nonschizophrenic nonaffective psychoses in relatives. Arch Gen Psychiatry 1993 50 : 645 652. (Pubitemid 23229273)
8. Lichtenstein P, Yip BH, Bjork C et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009 373 : 234 239.
9. Cardno AG, Rijsdijk FV, Sham PC, Murray RM, McGuffin P. A twin study of genetic relationships between psychotic symptoms. Am J Psychiatry 2002 159 : 539 545.
10. Craddock N, Owen MJ. Rethinking psychosis: the disadvantages of a dichotomous classification now outweigh the advantages. World Psychiatry 2007 6 : 84 91.
11. Kitamura T, Okazaki Y, Fujinawa A, Yoshino M, Kasahara Y. Symptoms of psychoses. A factor-analytic study. Br J Psychiatry 1995 166 : 236 240.
12. McGorry PD, Bell RC, Dudgeon PL, Jackson HJ. The dimensional structure of first episode psychosis: an exploratory factor analysis. Psychol Med 1998 28 : 935 947.
13. Van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med 2009 39 : 179 195.
14. Angst J. The bipolar spectrum. Br J Psychiatry 2007 190 : 189 191.
15. Hanssen M, Bak M, Bijl R, Vollebergh W, van Os J. The incidence and outcome of subclinical psychotic experiences in the general population. Br J Clin Psychol 2005 44 : 181 191. (Pubitemid 40873432)
16. Cougnard A, Marcelis M, Myin-Germeys I et al. Does normal developmental expression of psychosis combine with environmental risk to cause persistence of psychosis? A psychosis proneness-persistence model. Psychol Med 2007 37 : 513 527.
17. Lataster T, Myin-Germeys I, Derom C, Thiery E, van Os J. Evidence that self-reported psychotic experiences represent the transitory developmental expression of genetic liability to psychosis in the general population. Am J Med Genet B Neuropsychiatr Genet DOI : [Epub ahead of print].
18. Van Os J, Hanssen M, Bijl R-V, Ravelli A. Straus (1969) revisited: A psychosis continuum in the general population? Schizophr Res 2000 45 : 11 20.
19. Maric N, Myin-Germeys I, Delespaul P, De Graaf R, Vollebergh W, Van Os J. Is our concept of schizophrenia influenced by Berkson's bias? Soc Psychiatry Psychiatr Epidemiol 2004 39 : 600 605.
20. Regeer E, Krabbendam L, De Graaf R, Ten Have M, Nolen WA, Van Os J. Berkson's bias and the mood dimensions of bipolar disorder. Int J Methods Psychiatr Res (in press).
21. Hanssen MS, Bijl RV, Vollebergh W, van Os J. Self-reported psychotic experiences in the general population: a valid screening tool for DSM-III-R psychotic disorders? Acta Psychiatr Scand 2003 107 : 369 377.
22. Poulton R, Caspi A, Moffitt TE, Cannon M, Murray R, Harrington H. Children's self-reported psychotic symptoms and adult schizophreniform disorder: A 15-year longitudinal study [In Process Citation]. Arch Gen Psychiatry 2000 57 : 1053 1058.
23. Peters ER, Joseph SA, Garety PA. Measurement of delusional ideation in the normal population: introducing the PDI (Peters et al. Delusions Inventory). Schizophr Bull 1999 25 : 553 576.
24. Dominguez M, Wichers M, Lieb R, Wittchen H-U, van Os J. Evidence that onset of clinical psychosis is the outcome of progressively more persistent subclinical psychotic experiences: an 8-year cohort study. Schizophr Bull Doi
25. Perala J, Suvisaari J, Saarni SI et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry 2007 64 : 19 28.
26. Van Os J, Verdoux H. Diagnosis and classification of schizophrenia: Categories versus dimensions, distributions versus disease. In : Murray RM, Jones PB, Susser E, Van Os J, Cannon M, eds. The epidemiology of schizophrenia (ISBN 052177540X). Cambridge : Cambridge University Press, 2003 : 364 411.
27. Peralta V, Cuesta MJ. Diagnostic significance of Schneider's first-rank symptoms in schizophrenia. Comparative study between schizophrenic and non- schizophrenic psychotic disorders. Br J Psychiatry 1999 174 : 243 248.
28. Sackett DL, Richardson WS, Rosenberg W, Haynes RB. Evidence-based medicine. New York : Churchill Livingstone, 1997.
29. Krabbendam L, Arts B, van Os J, Aleman A. Cognitive functioning in patients with schizophrenia and bipolar disorder: A quantitative review. Schizophr Res 2005 80 : 137 149.
30. Van Os J, Gilvarry C, Bale R et al. Diagnostic value of the DSM and ICD categories of psychosis: An evidence-based approach. Soc Psychiatry Psychiatr Epidemiol 2000 35 : 305 311.
31. Cuesta MJ, Peralta V, Zarzuela A. Empirical validation of competing definitions of schizophrenia: a poly-diagnostic study of cognitive impairment in non-affective psychosis. Schizophr Res 2007 95 : 39 47.
32. Gold JM. Is cognitive impairment in schizophrenia ready for diagnostic prime time? World Psychiatry 2008 7 : 32 33.
33. Carpenter WT Jr., Arango C, Buchanan RW, Kirkpatrick B. Deficit psychopathology and a paradigm shift in schizophrenia research. Biol Psychiatry 1999 46 : 352 360.
34. Carpenter WT Jr., Heinrichs DW, Wagman AM. Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 1988 145 : 578 583.
35. Dominguez M, Viechtbauer W, Simons CJ, van Os J, Krabbendam L. Are psychotic psychopathology and neurocognition orthogonal? A systematic review of their associations. Psychol Bull 2009 135 : 157 171.
36. Eaton WW, Thara R, Federman B, Melton B, Liang KY. Structure and course of positive and negative symptoms in schizophrenia. Arch Gen Psychiatry 1995 52 : 127 134.
37. Flaum M, Andreasen N. The reliability of distinguishing primary versus secondary negative symptoms. Compr Psychiatry 1995 36 : 421 427.
38. Remington G, Chong SA, Kapur S. Distinguishing change in primary and secondary negative symptoms. Am J Psychiatry 1999 156 : 974 975.
39. Tarrier N. Negative symptoms in schizophrenia: comments from a clinical psychology perspective. Schizophr Bull 2006 32 : 231 233.
40. Van Os J. Commentary on "A default analysis for schizophrenia research". Schizophr Bull 2000 26 : 163 165.
41. Artaloytia JF, Arango C, Lahti A et al. Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers. Am J Psychiatry 2006 163 : 488 493.
42. Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 2003 160 : 13 23.
43. Brockington IF, Roper A, Copas J et al. Schizophrenia, bipolar disorder and depression. A discriminant analysis, using 'lifetime' psychopathology ratings. Br J Psychiatry 1991 159 : 485 494.
44. Mortensen PB, Pedersen CB, Melbye M, Mors O, Ewald H. Individual and familial risk factors for bipolar affective disorders in Denmark. Arch Gen Psychiatry 2003 60 : 1209 1215.
45. Arts B, Jabben N, Krabbendam L, van Os J. Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychol Med 2008 38 : 771 785.
46. Cannon M, Caspi A, Moffitt TE et al. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry 2002 59 : 449 456.
47. Cardno AG, Sham PC, Farmer AE, Murray RM, McGuffin P. Heritability of Schneider's first-rank symptoms. Br J Psychiatry 2002 180 : 35 38.
48. Murray RM, Sham P, Van Os J, Zanelli J, Cannon M, McDonald C. A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr Res 2004 71 : 405 416.
49. Van Os J, Gilvarry C, Bale R et al. To what extent does symptomatic improvement result in better outcome in psychotic illness? Psychol Med 1999 29 : 1183 1195.
50. Dikeos DG, Wickham H, McDonald C et al. Distribution of symptom dimensions across Kraepelinian divisions. Br J Psychiatry 2006 189 : 346 353.
51. Allardyce J, McCreadie RG, Morrison G, van Os J. Do symptom dimensions or categorical diagnoses best discriminate between known risk factors for psychosis? Soc Psychiatry Psychiatr Epidemiol 2007 42 : 429 437.
52. Van Os J, Fahy TA, Jones P et al. Psychopathological syndromes in the functional psychoses: associations with course and outcome. Psychol Med 1996 26 : 161 176. (Pubitemid 26031812)
53. Van Os J, Gilvarry C, Bale R et al. A comparison of the utility of dimensional and categorical representations of psychosis. UK700 Group. Psychol Med 1999 29 : 595 606.
54. Maj M, Pirozzi R, Formicola AM, Bartoli L, Bucci P. Reliability and validity of the DSM-IV diagnostic category of schizoaffective disorder: preliminary data. J Affect Disord 2000 57 : 95 98.
55. Keller MB, Klein DN, Hirschfeld RM et al. Results of the DSM-IV mood disorders field trial. Am J Psychiatry 1995 152 : 843 849.
56. Leff J. Book review: madness explained. psychosis and human nature. Br J Psychiatry 2004 184 : 374 375.
57. Allardyce J, Morrison G, Van Os J, Kelly J, Murray RM, McCreadie RG. Schizophrenia is not disappearing in south-west Scotland. Br J Psychiatry 2000 177 : 38 41.
58. Sato M. Renaming schizophrenia: a Japanese perspective. World Psychiatry 2006 5 : 53 55.
59. Schultz W. Multiple dopamine functions at different time courses. Annu Rev Neurosci 2007 30 : 259 288.
60. Berridge KC, Robinson TE. Parsing reward. Trends Neurosci 2003 26 : 507 513.
61. Jensen J, Willeit M, Zipursky RB et al. The formation of abnormal associations in schizophrenia: neural and behavioral evidence. Neuropsychopharmacology 2008 33 : 473 479.
62. Roiser JP, Stephan KE, Den Ouden HE, Barnes TR, Friston KJ, Joyce EM. Do patients with schizophrenia exhibit aberrant salience? Psychol Med 2009 39 : 199 209.
63. Murray GK, Corlett PR, Clark L et al. Substantia nigra/ventral tegmental reward prediction error disruption in psychosis. Mol Psychiatry 2008 13 : 267 276.
64. Kapur S. How antipsychotics become anti-'psychotic'- from dopamine to salience to psychosis. Trends Pharmacol Sci 2004 25 : 402 406.
65. Fine C, Gardner M, Craigie J, Gold I. Hopping, skipping or jumping to conclusions? Clarifying the role of the JTC bias in delusions. Cogn Neuropsychiatry 2007 12 : 46 77.
66. Jablensky A. Subtyping schizophrenia: implications for genetic research. Mol Psychiatry 2006 11 : 815 836.
67. Van Os J. A salience dysregulation syndrome. Br J Psychiatry 2009 194 : 101 103.